US Patent Issued to NAPA THERAPEUTICS, BUCK INSTITUTE FOR RESEARCH ON AGING on Dec. 30 for "Heteroaryl amide inhibitors of CD38" (American, British Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,451, issued on Dec. 30, was assigned to NAPA THERAPEUTICS Ltd. (Ramsey, Isle of Man) and BUCK INSTITUTE FOR RESEARCH ON AGING (Novato, Calif.).

"Heteroaryl amide inhibitors of CD38" was invented by Robert A. Volkmann (Mystic, Conn.), Jotham W. Coe (Niantic, Conn.), Eric Verdin (Mill Valley, Calif.), Rosalba Perrone (San Francisco), Margaret Jackson (Sudbury, Mass.), Frederick R. Nelson (Groton, Conn.), Elena Silva (Novato, Calif.) and Steve Felstead (Earlston, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are heteroaryl amide inhibitors of CD38 and methods of making and using the same in disease and disorder treatment."

The...